Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation.

PubWeight™: 4.17‹?› | Rank: Top 1%

🔗 View Article (PMC 3805478)

Published in BMJ on August 06, 2013

Authors

Xian Qi1, Yan-Hua Qian, Chang-Jun Bao, Xi-Ling Guo, Lun-Biao Cui, Fen-Yang Tang, Hong Ji, Yong Huang, Pei-Quan Cai, Bing Lu, Ke Xu, Chao Shi, Feng-Cai Zhu, Ming-Hao Zhou, Hua Wang

Author Affiliations

1: Department of Acute Infectious Disease Control and Prevention, Jiangsu Province Center for Disease Control and Prevention, Nanjing, Jiangsu 210009, China.

Articles citing this

Nosocomial transmission of avian influenza A (H7N9) virus in China: epidemiological investigation. BMJ (2015) 1.47

Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J (2014) 1.43

Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection. Clin Infect Dis (2015) 1.27

One family cluster of avian influenza A(H7N9) virus infection in Shandong, China. BMC Infect Dis (2014) 1.26

Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J Virol (2013) 1.22

Pandemic potential of avian influenza A (H7N9) viruses. Trends Microbiol (2014) 1.16

A combination of serological assays to detect human antibodies to the avian influenza A H7N9 virus. PLoS One (2014) 1.11

Distinguishing Between Reservoir Exposure and Human-to-Human Transmission for Emerging Pathogens Using Case Onset Data. PLoS Curr (2014) 1.10

Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model. J Virol (2013) 1.09

Asymptomatic, mild, and severe influenza A(H7N9) virus infection in humans, Guangzhou, China. Emerg Infect Dis (2014) 1.08

Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck. Nat Commun (2015) 1.08

Host adaptation and transmission of influenza A viruses in mammals. Emerg Microbes Infect (2014) 1.06

Transmission of influenza A viruses. Virology (2015) 0.99

Influenza A virus isolation, culture and identification. Nat Protoc (2014) 0.97

Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China. BMC Infect Dis (2014) 0.96

GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza. PLoS One (2014) 0.94

Avian influenza A viruses: from zoonosis to pandemic. Future Virol (2014) 0.94

Clinical severity of human infections with avian influenza A(H7N9) virus, China, 2013/14. Euro Surveill (2014) 0.93

Estimates of the demand for mechanical ventilation in the United States during an influenza pandemic. Clin Infect Dis (2015) 0.93

Continuing Reassortant of H5N6 Subtype Highly Pathogenic Avian Influenza Virus in Guangdong. Front Microbiol (2016) 0.90

Pathogen inactivation technologies for cellular blood components: an update. Transfus Med Hemother (2014) 0.90

Effect of Live Poultry Market Closure on Avian Influenza A(H7N9) Virus Activity in Guangzhou, China, 2014. Emerg Infect Dis (2015) 0.90

Determinants of virulence of influenza A virus. Eur J Clin Microbiol Infect Dis (2013) 0.89

Early response to the emergence of influenza A(H7N9) virus in humans in China: the central role of prompt information sharing and public communication. Bull World Health Organ (2013) 0.89

Quantification of bird-to-bird and bird-to-human infections during 2013 novel H7N9 avian influenza outbreak in China. PLoS One (2014) 0.89

Family clusters of avian influenza A H7N9 virus infection in Guangdong Province, China. J Clin Microbiol (2014) 0.87

Comparison of characteristics between patients with H7N9 living in rural and urban areas of Zhejiang Province, China: a preliminary report. PLoS One (2014) 0.86

Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity. Sci Rep (2013) 0.86

Identifying areas with a high risk of human infection with the avian influenza A (H7N9) virus in East Asia. J Infect (2014) 0.85

Standardizing scenarios to assess the need to respond to an influenza pandemic. Clin Infect Dis (2015) 0.85

Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs. PLoS One (2015) 0.84

Human to human transmission of H7N9. BMJ (2013) 0.83

Pandemic influenza viruses: time to recognize our inability to predict the unpredictable and stop dangerous gain-of-function experiments. EMBO Mol Med (2013) 0.83

Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic? Vaccines (Basel) (2015) 0.83

Novel avian-origin influenza A (H7N9) virus attachment to the respiratory tract of five animal models. J Virol (2014) 0.82

A family cluster of three confirmed cases infected with avian influenza A (H7N9) virus in Zhejiang Province of China. BMC Infect Dis (2014) 0.82

Serologic screenings for H7N9 from three sources among high-risk groups in the early stage of H7N9 circulation in Guangdong Province, China. Virol J (2014) 0.82

Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro Surveill (2015) 0.82

Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel. J Med Chem (2016) 0.82

Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. Clin Infect Dis (2015) 0.81

Knowledge, attitudes and practices relating to influenza A(H7N9) risk among live poultry traders in Guangzhou City, China. BMC Infect Dis (2014) 0.81

Cluster of human infections with avian influenza A (H7N9) cases: a temporal and spatial analysis. Int J Environ Res Public Health (2015) 0.81

An overview of the characteristics of the novel avian influenza A H7N9 virus in humans. Front Microbiol (2015) 0.80

The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model. PLoS One (2015) 0.79

Quantifying the fitness advantage of polymerase substitutions in Influenza A/H7N9 viruses during adaptation to humans. PLoS One (2013) 0.79

Avian Influenza A(H7N9) virus antibodies in close contacts of infected persons, China, 2013-2014. Emerg Infect Dis (2015) 0.79

Preliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus. Int J Biol Sci (2014) 0.79

Sialic acid-binding protein Sp2CBMTD protects mice against lethal challenge with emerging influenza A (H7N9) virus. Antimicrob Agents Chemother (2014) 0.79

Economic burden and its associated factors of hospitalized patients infected with A (H7N9) virus: a retrospective study in Eastern China, 2013-2014. Infect Dis Poverty (2016) 0.78

A clinical prediction rule for diagnosing human infections with avian influenza A(H7N9) in a hospital emergency department setting. BMC Med (2014) 0.78

Residues 41V and/or 210D in the NP protein enhance polymerase activities and potential replication of novel influenza (H7N9) viruses at low temperature. Virol J (2015) 0.78

Development of rapid immunochromatographic test for hemagglutinin antigen of H7 subtype in patients infected with novel avian influenza A (H7N9) virus. PLoS One (2014) 0.78

Three mutations switch H7N9 influenza to human-type receptor specificity. PLoS Pathog (2017) 0.77

Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses. PLoS One (2014) 0.77

Live Bird Exposure among the General Public, Guangzhou, China, May 2013. PLoS One (2015) 0.77

Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells. PLoS One (2014) 0.76

Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model. Antimicrob Agents Chemother (2015) 0.76

Using shared needles for subcutaneous inoculation can transmit bluetongue virus mechanically between ruminant hosts. Sci Rep (2016) 0.76

MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication. PLoS One (2016) 0.76

Who acquires infection from whom and how? Disentangling multi-host and multi-mode transmission dynamics in the 'elimination' era. Philos Trans R Soc Lond B Biol Sci (2017) 0.75

Controlling novel avian influenza A (H7N9) at animal sources. BMJ (2013) 0.75

Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses. Sci Rep (2016) 0.75

Multiple gene mutations identified in patients infected with influenza A (H7N9) virus. Sci Rep (2016) 0.75

Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment. Clin Transl Immunology (2017) 0.75

Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013. Euro Surveill (2014) 0.75

Epidemiological and molecular characteristics of the PB1-F2 proteins in H7N9 influenza viruses, Jiangsu. Biomed Res Int (2015) 0.75

Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses. Int J Environ Res Public Health (2017) 0.75

Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults. PLoS One (2016) 0.75

Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus. Infect Genet Evol (2016) 0.75

Significantly elevated number of human infections with H7N9 virus in Jiangsu in eastern China, October 2016 to January 2017. Euro Surveill (2017) 0.75

Radiological Features of Human Infection with Avian Influenza A H7N9 Virus: A Report of Three Cases. Iran J Public Health (2014) 0.75

Knowledge, attitudes, and practices of Hong Kong population towards human A/H7N9 influenza pandemic preparedness, China, 2014. BMC Public Health (2015) 0.75

Nosocomial Co-Transmission of Avian Influenza A(H7N9) and A(H1N1)pdm09 Viruses between 2 Patients with Hematologic Disorders. Emerg Infect Dis (2016) 0.75

Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model. Sci Rep (2016) 0.75

Challenges and Strategies of Laboratory Diagnosis for Newly Emerging Influenza Viruses in Taiwan: A Decade after SARS. Biomed Res Int (2015) 0.75

The Potential for Low Pathogenic Avian H7 Influenza A Viruses to Replicate and Cause Disease in a Mammalian Model. J Virol (2016) 0.75

Analysis of the full-length genome of a novel strain of the H7N9 avian influenza virus. Exp Ther Med (2014) 0.75

Differences in the Epidemiology of Childhood Infections with Avian Influenza A H7N9 and H5N1 Viruses. PLoS One (2016) 0.75

Articles cited by this

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol (2007) 168.76

Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88

Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol (2001) 21.17

Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 14.59

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet (2013) 10.66

Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27

Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet (2013) 6.10

Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med (2013) 5.38

Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 4.44

Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17

Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med (2013) 3.88

Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77

H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science (2013) 3.33

Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis (2009) 2.80

Live-animal markets and influenza A (H7N9) virus infection. N Engl J Med (2013) 2.43

H7N9 is a virus worth worrying about. Nature (2013) 1.98

Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human. Sci China Life Sci (2013) 1.66

Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes Infect (2013) 1.59

Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. Euro Surveill (2005) 1.46

The role of host genetics in susceptibility to influenza: a systematic review. PLoS One (2012) 1.39

Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9). Biosci Trends (2013) 1.29

Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. J Clin Virol (2009) 1.24

H7N9 virus is more transmissible and harder to detect than H5N1, say experts. BMJ (2013) 0.99

From SARS to H7N9: will history repeat itself? Lancet (2013) 0.98

Articles by these authors

Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88

Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med (2011) 13.18

Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med (2008) 8.77

PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A (2009) 8.25

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet (2010) 7.11

Exosomes: extracellular organelles important in intercellular communication. J Proteomics (2010) 6.47

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science (2007) 6.04

Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87

Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science (2005) 5.50

Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med (2005) 5.05

Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet (2012) 4.98

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72

Hospital lymph node examination rates and survival after resection for colon cancer. JAMA (2007) 4.55

A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med (2009) 4.20

Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med (2010) 4.07

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet (2009) 3.97

Telomerase modulates Wnt signalling by association with target gene chromatin. Nature (2009) 3.96

A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis (2011) 3.91

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet (2013) 3.74

The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A (2008) 3.65

Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis (2006) 3.65

Effect of socioeconomic status on treatment and mortality after stroke. Stroke (2002) 3.44

Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA (2010) 3.40

Coping with out-of-pocket health payments: empirical evidence from 15 African countries. Bull World Health Organ (2008) 3.33

Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18

Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol (2008) 3.13

Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3. Hepatology (2015) 3.10

High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol (2005) 3.10

Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science (2013) 3.10

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res (2009) 3.07

To retain or remove user fees?: reflections on the current debate in low- and middle-income countries. Appl Health Econ Health Policy (2006) 3.06

Long-term efficacy of a hepatitis E vaccine. N Engl J Med (2015) 3.00

3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med (2004) 2.96

Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev Cell (2005) 2.86

Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe (2009) 2.81

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity (2002) 2.75

Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65

Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay. J Clin Microbiol (2011) 2.63

Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ (2002) 2.56

A new stage of the nutrition transition in China. Public Health Nutr (2002) 2.52

Atlas - a data warehouse for integrative bioinformatics. BMC Bioinformatics (2005) 2.51

A 160-kilobit molecular electronic memory patterned at 10(11) bits per square centimetre. Nature (2007) 2.48

Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 2.47

Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods (2012) 2.46

Live-animal markets and influenza A (H7N9) virus infection. N Engl J Med (2013) 2.43

PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol (2007) 2.40

Universal coverage of health services: tailoring its implementation. Bull World Health Organ (2008) 2.30

Sex differences in carotid endarterectomy outcomes: results from the Ontario Carotid Endarterectomy Registry. Stroke (2003) 2.28

An aluminum-activated citrate transporter in barley. Plant Cell Physiol (2007) 2.24

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann Diagn Pathol (2011) 2.23

The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst (2013) 2.20

Diagnosis and treatment of abdominal cocoon: a report of 24 cases. Am J Surg (2009) 2.19

Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain (2004) 2.17

Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17

Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc (2013) 2.14

Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol (2004) 2.11

Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics (2009) 2.08

Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis (2006) 2.07

Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension (2006) 2.05

Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension (2004) 2.05

Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest (2004) 2.02

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med (2014) 2.01

An efficient approach to Aspidosperma alkaloids via [4 + 2] cycloadditions of aminosiloxydienes: stereocontrolled total synthesis of (+/-)-tabersonine. Gram-scale catalytic asymmetric syntheses of (+)-tabersonine and (+)-16-methoxytabersonine. Asymmetric syntheses of (+)-aspidospermidine and (-)-quebrachamine. J Am Chem Soc (2002) 2.00

Measurement of bone mineral density in the tunnel regions for anterior cruciate ligament reconstruction by dual-energy X-ray absorptiometry, computed tomography scan, and the immersion technique based on Archimedes' principle. Arthroscopy (2012) 1.99

Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol (2006) 1.98

Several acneiform papules and nodules on the neck. J Dtsch Dermatol Ges (2013) 1.98

Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr (2011) 1.98

Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol (2004) 1.97

Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat Immunol (2009) 1.96

Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology (2011) 1.93

Understanding the nutrition transition: measuring rapid dietary changes in transitional countries. Public Health Nutr (2002) 1.93

Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol (2010) 1.92

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci (2008) 1.92

A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. Cardiovasc Res (2007) 1.91

WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway. J Am Soc Nephrol (2009) 1.87

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet (2012) 1.86

The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo. Cell (2012) 1.84

Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology (2010) 1.82

Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med (2013) 1.81

Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat Immunol (2012) 1.81

Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci U S A (2009) 1.81

Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol (2012) 1.80

The Putative RNA-dependent RNA polymerase RDR6 acts synergistically with ASYMMETRIC LEAVES1 and 2 to repress BREVIPEDICELLUS and MicroRNA165/166 in Arabidopsis leaf development. Plant Cell (2005) 1.80

Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics (2002) 1.75

New caged coumarin fluorophores with extraordinary uncaging cross sections suitable for biological imaging applications. J Am Chem Soc (2004) 1.74

Site-directed transposon integration in human cells. Nucleic Acids Res (2007) 1.74

Spatial-temporal clusters and risk factors of hand, foot, and mouth disease at the district level in Guangdong Province, China. PLoS One (2013) 1.74

BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology (2005) 1.74

Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario Carotid Endarterectomy Registry. Stroke (2003) 1.74

Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin. Nat Cell Biol (2004) 1.73

Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol (2011) 1.72

Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis (2011) 1.70

Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer (2004) 1.70

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology (2011) 1.69

Constitutive activating mutation of the FGFR3b in oral squamous cell carcinomas. Int J Cancer (2005) 1.69

Two-year outcome of a combination of weight loss therapies for type 2 diabetes. Diabetes Care (2005) 1.68

Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS (2009) 1.68